Loading
Latest filing published 17 Mar 2023 for Aralez Pharmaceuticals Canada Inc. (formerly Nuvo Pharmaceuticals Inc. (d/b/a Miravo Healthcare)).
No signal scores available.
This profile gathers the share dealings of Daniel Chicoine in Aralez Pharmaceuticals Canada Inc. (formerly Nuvo Pharmaceuticals Inc. (d/b/a Miravo Healthcare)). Altogether 2 filings, all relating to 14 March 2023.
Not one of the filings records a straightforward purchase or sale on the market. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
The latest filing, published on 17 March 2023, reports a transaction in Aralez Pharmaceuticals Canada Inc. (formerly Nuvo Pharmaceuticals Inc. (d/b/a Miravo Healthcare)). These figures are compiled from regulatory filings published by SEDI. They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations